Cytology-histology correlation of cervical Papanicolaou smears and biopsies performed at a single institution compared to those performed at different institutions
- PMID: 36148769
- DOI: 10.1111/cyt.13182
Cytology-histology correlation of cervical Papanicolaou smears and biopsies performed at a single institution compared to those performed at different institutions
Abstract
Objective: Cytology-histology correlation (CHC) is the gold standard of quality assurance in cytology laboratories to ensure appropriate patient treatment, and as an educational tool for cytology laboratory personnel. If cervical Pap smears (CPs) and cervical biopsies (CBs) are performed at different institutions, these benefits may be lost.
Methods: All CBs performed at our institution from 1 January 2019 to 31 December 2019 with adequate CPs performed in the 6 months prior to the CB were included in this retrospective review. We compared the CHC for CPs and CBs performed at a single institution to the CHC for CPs and CBs performed at different institutions, with a focus on the proportion of overcalls on CPs, as those are the most challenging discrepant CHC to manage clinically. We used the American Society of Cytology guidelines for our discrepancy assessment grid. A Chi-squared test was used to compare the proportions of the populations. The P-value was set at < 0.05.
Results: Of the 305 CBs in our study population, 69 had a CP performed at our institution and 236 had a CP performed at an outside institution. The CHC for CBs and CPs performed at a single institution showed statistically significantly less disagreement than the CHC for those performed at different institutions (P < 0.05). Further, CBs and CPs performed at a single institution had statistically significantly fewer overcalls than CBs and CPs performed at different institutions (P < 0.05).
Conclusion: This study further supports the use of CHC, and in light of our findings we recommend that a patient's CPs and CBs are performed at the same institution. If performing a CP and CB at the same institution is not feasible, a prospective consultation review of the CP by the institution performing the CB should be strongly considered. Further study, including an evaluation of the reason for the discrepancy in discordant cases may better elucidate the reasons for better CHC agreement when CP and CB are performed at the same institution.
© 2022 John Wiley & Sons Ltd.
Similar articles
-
Reappraisal of cytology-histology correlation in cervical cytology based on the recent American Society of Cytopathology guidelines (2017) at a cancer research centre.Cytopathology. 2020 Jan;31(1):53-58. doi: 10.1111/cyt.12774. Epub 2019 Oct 23. Cytopathology. 2020. PMID: 31535740
-
Quality metrics in cervical cytopathology: A single institutional study.Cytopathology. 2022 Mar;33(2):230-235. doi: 10.1111/cyt.13082. Epub 2021 Dec 16. Cytopathology. 2022. PMID: 34854153
-
Cell block as an adjunct to conventional Papanicolaou smear for diagnosis of cervical cancer in resource-limited settings.Cytopathology. 2007 Oct;18(5):309-15. doi: 10.1111/j.1365-2303.2007.00477.x. Epub 2007 Aug 6. Cytopathology. 2007. PMID: 17681012
-
Liquid-based cytology: evaluation of effectiveness, cost-effectiveness, and application to present practice.J Natl Compr Canc Netw. 2004 Nov;2(6):597-611. doi: 10.6004/jnccn.2004.0050. J Natl Compr Canc Netw. 2004. PMID: 19780303 Review.
-
Abnormal cervical cytology: new names, familiar smears.J Am Acad Nurse Pract. 2003 Oct;15(10):444-9. doi: 10.1111/j.1745-7599.2003.tb00330.x. J Am Acad Nurse Pract. 2003. PMID: 14606133 Review.
References
REFERENCES
-
- Electronic Code of Federal Regulations. Updated August 30, 2021. Title 42, Chapter IV, Subchapter G, Part 493, Subpart K, §493.1274. https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=1&SID=323e6c22690f1331b...
-
- Gupta R, Hariprasad R, Dhanasekaran K, et al. Reappraisal of cytology-histology correlation in cervical cytology based on the recent American Society of Cytopathology guidelines (2017) at a cancer research center. Cytopathology. 2020;31(1):53-58. doi:10.1111/cyt.12774
-
- Crothers BA. Cytologic-histologic correlation: Where are we now, and where are we going? Cancer Cytopathol. 2018;126(5):301-308. doi:10.1002/cncy.21991
-
- Raab SS, Grzybicki DM. Cytologic-histologic correlation. Cancer Cytopathol. 2011;119(5):293-309. doi:10.1002/cncy.20165
-
- Vrbin CM, Grzybicki DM, Zaleski MS, Raab SS. Variability in cytologic-histologic correlation practices and implications for patient safety. Arch Pathol Lab Med. 2005;129(7):893-898. doi:10.5858/2005-129-893-VICCPA
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous